Lisanti Capital Growth, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
Lisanti Capital Growth, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$8,382,508
-45.7%
147,320
-58.0%
1.14%
-45.4%
Q2 2022$15,441,000
+40.6%
350,935
+33.2%
2.10%
+48.8%
Q1 2021$10,984,000
+2016.4%
263,460
+779.3%
1.41%
+158.5%
Q4 2015$519,000
+18.2%
29,963
+2.2%
0.54%
+194.6%
Q4 2013$439,00029,3150.18%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders